New: A Guided Questionnaire for Clinical Trial Matching
No more blank text boxes. Just answer simple questions about your condition.
The Problem with Blank Text Boxes
When we launched ClinTrialFinder, the interface was simple: a text box where you describe your condition, and AI does the rest.
Simple for us. Not so simple for patients.
Early users would type things like "I have lung cancer and want to find a trial"—too vague for meaningful trial matching. Which type of lung cancer? What stage? What treatments have you already tried? Without these details, the system can't find the right trials.
That pattern made us realize something: most patients and caregivers don't know what clinical information is relevant for finding trials. They know their diagnosis, maybe their stage. But what about biomarkers? Specific drug names? Treatment lines?
The blank text box was a barrier, not an invitation.
Before and After
Before
An empty text box with a blinking cursor.
"Describe your condition..."
Users freeze. What should I write? How detailed? What matters?
After
A guided questionnaire that asks one thing at a time.
Disease → Diagnosis date → Stage → Treatments → Biomarkers → Done.
Just pick from the options. No typing required for most steps.
How It Works
- Tell us your condition. Start typing and select from suggestions, or type any disease name. We support everything from common cancers to rare diseases to non-cancer conditions like diabetes or depression.
- When were you diagnosed? A simple multiple-choice question. Some trials target newly diagnosed patients; others need patients who've been living with the condition for a while.
- What stage or risk category? The question adapts to your disease. Solid tumors get spread-based staging (Stage I–IV). Blood cancers get their own classification—AML asks about ELN risk category, lymphoma uses Ann Arbor staging, myeloma uses ISS staging. Non-cancer conditions skip this step entirely.
- What treatments have you received? The system generates treatment categories specific to your disease, in chronological order. Select the categories, then pick your specific medications from a list. Can't find your drug? Type it in—we have autocomplete with 20–30 suggestions per category, covering drugs approved worldwide.
- Biomarker testing. Shows only the biomarkers that are clinically relevant and that you'd actually know about. For lung cancer: EGFR, ALK, PD-L1. For breast cancer: HER2, ER, PR. For depression: this step is skipped entirely.
- Your age and location. Optional country filter to find trials near you.
What Makes This Different
It adapts to your disease
The questionnaire isn't a fixed form. When you enter your disease, we use AI to generate the right questions:
- Breast cancer gets Surgery, Chemotherapy, Hormone Therapy, Targeted Therapy, and Immunotherapy—with drugs like trastuzumab, T-DM1, and CDK4/6 inhibitors.
- Acute myeloid leukemia gets Induction Chemotherapy, Consolidation, Targeted Therapy (FLT3 inhibitors, IDH inhibitors), and Stem Cell Transplant—no surgery, and instead of "How far has it spread?" it asks "What is your AML risk category?" (Favorable / Intermediate / Adverse).
- Depression gets Psychotherapy, Pharmacotherapy (SSRIs, SNRIs), Neuromodulation (ECT, TMS)—no staging, no biomarkers.
- Type 2 diabetes gets Oral Medications, Injectable Medications, Insulin Therapy—with HbA1c as a biomarker.
It knows drugs from everywhere
Clinical trials aren't limited to FDA-approved drugs. Patients in Asia may have received toripalimab or tislelizumab (approved in China). Patients in trials may have received investigational drugs. Our drug lists cover all major regulatory regions—FDA, EMA, NMPA, PMDA—plus drugs in late-stage clinical trials.
We also include newer drug types that many tools miss: antibody-drug conjugates (ADCs), bispecific antibodies, CAR-T cell therapies, and radiopharmaceuticals.
It skips what doesn't apply
Not every condition needs every question:
- Solid tumors (lung, breast, colon): 8 steps—spread-based staging and biomarkers
- Blood cancers (leukemia, lymphoma, myeloma): 8 steps—disease-specific staging (ELN risk, Ann Arbor, ISS) and biomarkers
- Non-cancer with biomarkers (diabetes): 7 steps—staging skipped, biomarkers shown
- Non-cancer without biomarkers (depression, infections): 6 steps—staging and biomarkers both skipped
The progress bar updates to reflect the actual number of steps for your condition.
Power users still have the text box
If you have a clinical summary from your doctor, you can still paste it directly. The questionnaire and text box are side by side—pick whichever works for you.
Why We Built This
Finding clinical trials shouldn't require medical expertise. A patient with breast cancer shouldn't need to know that "HER2-positive, hormone receptor-negative, stage IIIA adenocarcinoma" is what trial databases care about. They should be able to select "Breast Cancer," check "Spread to nearby areas," pick "Trastuzumab" from a list, and mark "HER2: Positive."
The result is the same high-quality, evidence-informed trial matching—just without the barrier of a blank text box.
Try It Now
Click "Answer Questions" on the landing page to start the guided questionnaire.
Questions or feedback? Contact us